My Sofia Valves – One Day Course

My Sofia Valves 2025 brought together international experts to discuss current advances and clinical challenges in transcatheter aortic valve interventions. The course focused on the latest developments in balloon-expandable valve technology, including the new-generation Myval OctaPro system, and highlighted key evidence from major trials such as LANDMARK and COMPARE. Through live cases, expert panels, and interactive discussions, participants explored important aspects of patient management, including antithrombotic therapy, the role of PCI in TAVI patients, and valve-in-valve procedures. The program also addressed controversial indications not currently recommended by guidelines, such as TAVI in asymptomatic patients, moderate aortic stenosis, and aortic regurgitation. The event concluded with the presentation of challenging and complication cases, providing a platform for practical learning and exchange of experience aimed at improving outcomes in structural heart interventions.